Survival analysis based on tumor response.
- Jeong-Ju Yoo (3666826)
- Jeong-Hoon Lee (313984)
- Sang Hwan Lee (507436)
- Minjong Lee (597002)
- Dong Hyeon Lee (313980)
- Yuri Cho (313981)
- Yun Bin Lee (530627)
- Su Jong Yu (313985)
- Hyo-Cheol Kim (530622)
- Yoon Jun Kim (313990)
- Jung-Hwan Yoon (313986)
- Chung Yong Kim (313987)
- Hyo-Suk Lee (297060)
Publication date
November 2014
DOIAbstract
<p>Responders (CR+PR according to mRECIST, dotted line) showed a better OS, as compared with non-responders (SD+PD, solid line), regardless of the presence of EHM, both (A) in the EHM group (median, 9.4 months vs. 6.5 months; <i>P</i> = 0.005) and (B) in the non-EHM group (median, 21.9 months vs. 10.8 months, <i>P</i> = 0.003).</p
Add to ORKG